Aruna Bio

11:15 AM - 11:30 AM, Tuesday, June 4, 2019 ・ Theater 2
For over twelve years, Aruna manufactured and provided neural stem cells to the world’s leading research organizations with unrivaled uniformity and scale. Today, Aruna Bio is advancing a new class of cell-free biologics, neural exosomes, for the treatment of central nervous system (CNS) injury and degenerative disorders. As experts in the design and scaling of neural-derived exosomes, Aruna Bio is rapidly moving toward clinical development of a new class of cell-free exosome biologics and exosome-mediated drug delivery systems. To date, our exosomes have demonstrated the ability to be safely administered intravenously in multiple doses with no adverse side effects, cross the blood-brain barrier non-invasively to reach the site of injury, reduce inflammation and enhance neural function, and improve motor function and behavioral outcomes in large and small preclinical models.
Not Provided.
Not Provided.
Company Type:
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided.
Chief Executive Officer
Aruna Bio